C u m b e r l a n d V a l l e y R e t i n a C o n s u l t a n t s
Welcome,         Profile    Billing    Logout  
 0 Trials 
9 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hu, Allen
VOYAGE, NCT04708145: Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Active, not recruiting
4
150
US
Aflibercept Injection, Eylea
Greater Houston Retina Research, Regeneron Pharmaceuticals, Clinical Trials Resource Group, LLC
Diabetic Retinopathy
09/24
09/24
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
Europe, Canada, US, RoW
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Active, not recruiting
2/3
75
US
Valeda Light Delivery System
LumiThera, Inc., National Eye Institute (NEI)
Dry Age-related Macular Degeneration
05/25
06/25
NCT05532735: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

Completed
2
16
US
ANXV
Annexin Pharmaceuticals AB, InFocus Clinical Research
Retinal Vein Occlusion
07/24
11/24
NCT05573100: The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Completed
2
67
US
CU06-1004, SAC-1004, CU06, CU06-RE
Curacle Co., Ltd., Théa Open Innovation, France
Diabetic Macular Edema
05/23
06/23
NCT05930561: 4D-150 in Patients With Diabetic Macular Edema

Recruiting
2
72
US
4D-150 IVT, Aflibercept IVT, Eylea
4D Molecular Therapeutics
Diabetic Macular Edema, Diabetic Retinopathy
02/28
07/28
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
i-SIGHT, NCT05447650: Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration

Active, not recruiting
N/A
95
US
i-Lumen(TM) AMD, i-Lumen(TM) AMD Sham
i-Lumen Scientific, Inc.
Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration
06/25
06/25
Stokes, Christie
No trials found
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Hu, Allen
VOYAGE, NCT04708145: Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial

Active, not recruiting
4
150
US
Aflibercept Injection, Eylea
Greater Houston Retina Research, Regeneron Pharmaceuticals, Clinical Trials Resource Group, LLC
Diabetic Retinopathy
09/24
09/24
ARCHER II, NCT06510816: A Study Investigating the Efficacy and Safety of Intravitreal (IVT) Injections of ANX007 in Participants With Geographic Atrophy (GA)

Recruiting
3
630
Europe, Canada, US, RoW
ANX007, Sham Administration
Annexon, Inc.
Geographic Atrophy
10/26
10/27
NCT04740671 / 2020-005364-57: A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD

Completed
3
410
Europe, US, RoW
HLX04-O, ranibizumab
Shanghai Henlius Biotech
Age Related Macular Degeneration
12/24
12/24
NCT06229665: Study of Photobiomodulation to Treat Dry Age-Related Macular Degeneration (LIGHTSITEIIIB)

Active, not recruiting
2/3
75
US
Valeda Light Delivery System
LumiThera, Inc., National Eye Institute (NEI)
Dry Age-related Macular Degeneration
05/25
06/25
NCT05532735: Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Retinal Vein Occlusion

Completed
2
16
US
ANXV
Annexin Pharmaceuticals AB, InFocus Clinical Research
Retinal Vein Occlusion
07/24
11/24
NCT05573100: The Study of CU06-1004 in Patients With Diabetic Macular Edema (DME)

Completed
2
67
US
CU06-1004, SAC-1004, CU06, CU06-RE
Curacle Co., Ltd., Théa Open Innovation, France
Diabetic Macular Edema
05/23
06/23
NCT05930561: 4D-150 in Patients With Diabetic Macular Edema

Recruiting
2
72
US
4D-150 IVT, Aflibercept IVT, Eylea
4D Molecular Therapeutics
Diabetic Macular Edema, Diabetic Retinopathy
02/28
07/28
PRISM, NCT05197270: 4D-150 in Patients with Neovascular (Wet) Age-Related Macular Degeneration

Recruiting
1/2
215
US
4D-150 IVT, Aflibercept IVT
4D Molecular Therapeutics
Neovascular (Wet) Age-Related Macular Degeneration
11/25
11/26
i-SIGHT, NCT05447650: Microcurrent Stimulation Therapy for Nonexudative Age-related Macular Degeneration

Active, not recruiting
N/A
95
US
i-Lumen(TM) AMD, i-Lumen(TM) AMD Sham
i-Lumen Scientific, Inc.
Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration
06/25
06/25
Stokes, Christie
No trials found

Download Options